appliedclinicaltrialsonline2d
ASTRO Trial Shows SC Tremfya Provides Significant Clinical Benefits in Moderately to Severely Active Ulcerative Colitis
Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...
appliedclinicaltrialsonline2d
SCOPE Summit 2025: Graham Clark on Ensuring Data Consitency Amid the Rise of Real-World Evidence
ACT: What are Phastar’s key objectives for attending SCOPE 2025, and how do you see the conference shaping discussions on statistical analysis and data-driven trial optimization? Clark: I think there ...
appliedclinicaltrialsonline2d
Best Practices for Reducing Risk Upfront in a Clinical Trial
In this video interview, Dominique Demolle, CEO of Cognivia, discusses how understanding the patient journey from the very beginning of a study can help mitigate risk and improve patient centricity.
appliedclinicaltrialsonline3d
SCOPE Summit 2025: Sebastien Coppe Discusses Advancing Innovation in Clinical Trials
In an interview with Applied Clinical Trials Associate Editor Don Tracy, Sebastien Coppe, CEO, One2Treat, talks challenges ...
appliedclinicaltrialsonline3d
Using AI/ML to Improve Patient Adherence
In this video interview, Dominique Demolle, CEO of Cognivia, talks artificial intelligence/machine learning and its potential ...
appliedclinicaltrialsonline4d
The Impact of Non-Adherence on Study Protocols
In this video interview, Dominique Demolle, CEO of Cognivia, highlights how patient non-adherence could increase trial ...
appliedclinicaltrialsonline4d
Accelerate Inclusive Enrollment and Delivery with Lightship
David MacMurchy, Chief Executive Officer at Lightship, offers some insights into the company's mission toward improving equity and diversity in clinical trials.